Upcoming IPOs to Watch This Week Include VVV, TTD, ELF

upcoming IPOsThe IPO calendar is fully booked with eight upcoming IPOs this week. These IPOs are expected to raise more than $1 billion combined, according to IPOScoop.com.

The eight companies on the upcoming IPO calendar are in a variety of industries, ranging from pharmaceuticals, tech, finance, and the beauty industry. There are no unicorn IPOs in this batch of upcoming IPOs, which are companies with a valuation greater than $1 billion.

The largest expected offering on our calendar for upcoming IPOs is Valvoline (NYSE: VVV).

Valvoline is one of the largest producers of motor oil in the United States, and its world headquarters are in Lexington, Kentucky. Valvoline has over 800 franchise and company instant oil change locations. Valvoline has a rich tradition, as it was the only motor oil recommended in the 1920s when the Model T was mass produced. Valvoline was also widely used to lubricate allied vehicles in WWII, and it started placing oil-change instructions on its labels in 1978 for the growing DIY car mechanic market.

Trending: Get the Best Investing Research Today to Grow Your Money

It's expected to raise up to $800 million from its IPO and set its share price between $20 and $23.

Now, here's the rest of this week's upcoming IPO calendar, including one IPO from a company that boasts some of the biggest retailers in the United States as its current customers.

7 Other Upcoming IPOs to Watch This Week

The Trade Desk (Nasdaq: TTD) is an ad-tech company that uses self-service technology to manage data-driven digital advertising campaigns. Its clients can create ads across different channels that focus on reaching people based on their specific interests and location. According to CNBC, the tech company has several politicians as its clients: Sen. Kelly Ayotte (R-NH), Sen. Roy Blunt (R-MO), and Sen. Ron Johnson (R-WI). The Trade Desk is looking to raise $70 million by selling over 4.6 million shares at $14 to $16 apiece.

Continue reading for six more upcoming IPOs this week that investors need to watch...

Novan Inc. (Nasdaq: NOVN) is a pharmaceutical company located in North Carolina. Novan wants to redefine the dermatology industry though the development and commercialization of innovative therapies using nitric oxide. Novan is using this IPO to fund clinical work on several different skin conditions. It has an acne drug that is on trial now known as SB204, and Novan could apply for FDA approval by the end of 2017. Novan is looking to raise $60 million and will price its shares between $11 and $13 each.

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

E.l.f Beauty (NYSE: ELF) is a Bay-area company that started in New York in 2004. The beauty company is led by CEO Tarang Amin, a former executive at Clorox and Schiff Nutrition. It has retail stores and over 200 employees between New York and the Bay Area. Amin's company sells low-price products, with the majority of products selling for $6 or less. It wants to raise $125 million at its IPO offering and sell shares for $14 to $16 per share.

CapStar Financial Holdings (Nasdaq: CSTR) is a holding company for Nashville-based CapStar Bank. CapStar was founded in 2007, and it bought Farmington Financial Group in 2014, adding residential mortgages to its portfolio. CapStar ranks No. 3 among local banks for market share by deposit and has $1.3 billion in assets. CSTR stock will be priced between $13.50 and $16.50 per share and is expected to raise $40 million.

Gridsum Holding (Nasdaq: GSUM) is a China-based analytic company looking to raise $86 million in its U.S. IPO. It was founded in 2005 by CEO Qi Guosheng and his COO Guofa Yu. It provides data analysis for digital intelligence and online marketing. Gridsum is expected to price its shares between $10.50 and $12.50.

Apptio (Nasdaq: APTI) develops technology business management software and was founded in 2007. The company has 250 customers, ranging from small companies to huge corporations like Starbucks Corp. (Nasdaq: SBUX), Target Corp. (NYSE: TGT), and Boeing Co. (NYSE: BA). Apptio plans to raise $84 million and set shares at a price range of $13 and $15.

AC Immune (Nasdaq: ACIU) is a Switzerland-based developer of drugs for the diagnosis and treatment of diseases such as Parkinson's and Alzheimer's. AC Immune was founded in 2013, and it's dedicated to becoming the global leader in personalized treatment of neurodegenerative diseases. It plans to raise $45 million and price its shares between $11 and $13.

Next Up: The Subprime Auto Loan Market Is About to Collapse - Here's How to Profit

Follow us on Twitter @moneymorning and like us on Facebook.